American Century Companies Inc. Invests $256,000 in InfuSystem Holdings, Inc. $INFU

Key Points

• American Century Companies Inc. has invested approximately $256,000 in InfuSystem Holdings, acquiring 47,624 shares, which is about 0.23% of the company.
• InfuSystem's stock ratings have varied, with Wall Street Zen lowering the rating from "strong-buy" to "buy," while other analysts maintain a consensus rating of "Strong Buy" with a target price of $12.50.
• Insider transactions revealed that Director Scott Shuda sold 5,752 shares, reducing his ownership by 5.77%, while 71.13% of the stock is held by institutional investors.

American Century Companies Inc. acquired a new position in InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 47,624 shares of the company's stock, valued at approximately $256,000. American Century Companies Inc. owned approximately 0.23% of InfuSystem at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Nuveen Asset Management LLC increased its stake in shares of InfuSystem by 14.1% in the fourth quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company's stock worth $730,000 after purchasing an additional 10,647 shares in the last quarter. BNP Paribas Financial Markets boosted its position in shares of InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock worth $58,000 after acquiring an additional 2,768 shares during the last quarter. Deutsche Bank AG boosted its position in shares of InfuSystem by 148.3% during the fourth quarter. Deutsche Bank AG now owns 27,671 shares of the company's stock worth $234,000 after acquiring an additional 16,526 shares during the last quarter. Two Sigma Investments LP boosted its position in shares of InfuSystem by 40.4% during the fourth quarter. Two Sigma Investments LP now owns 36,252 shares of the company's stock worth $306,000 after acquiring an additional 10,427 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of InfuSystem by 7.7% during the fourth quarter. Northern Trust Corp now owns 186,741 shares of the company's stock worth $1,578,000 after acquiring an additional 13,333 shares during the last quarter. 71.13% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at InfuSystem

In other news, Director Scott Shuda sold 5,752 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.67, for a total value of $55,621.84. Following the sale, the director owned 94,000 shares of the company's stock, valued at approximately $908,980. This represents a 5.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 11.40% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on INFU. Wall Street Zen lowered shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 14th. Roth Capital began coverage on shares of InfuSystem in a research report on Tuesday, July 22nd. They set a "buy" rating and a $12.00 target price for the company. Three analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of "Strong Buy" and a consensus target price of $12.50.

InfuSystem Price Performance

INFU stock opened at $10.16 on Friday. InfuSystem Holdings, Inc. has a 52 week low of $4.61 and a 52 week high of $11.04. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The company has a fifty day simple moving average of $7.62 and a two-hundred day simple moving average of $6.41. The firm has a market capitalization of $207.53 million, a P/E ratio of 169.36 and a beta of 1.82.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.